Salix develops prescription drugs and medical devices that prevent and treat various gastrointestinal disorders.

Salix was founded in 1989[1] in Sunnyvale, California by Randy W. Hamilton and Lorin K. Johnson.

In 2013, Salix acquired Santarus and its products Uceris (oral), Zegerid, Glumetza, Cycloset and Ruconest for $2.6B.

Lumacan is a photodynamic colorectal diagnostic intended to significantly improve the detection of precancerous and cancerous lesions in the colon through fluorescence diagnosis.

[3] In February 2015, Valeant Pharmaceuticals announced it would acquire Salix for $14.5 billion, creating the world leader in gastrointestinal drugs.